Rubric Capital Management LP (“Rubric”), an investment advisor whose funds and accounts collectively own approximately 14% of the outstanding equity of Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo ...
Upon reading the investor presentation issued by Xperi on April 30, 2024, we were struck by one, overriding thought: “What contempt this Board must have for its own stockholders.” While we are not ...